Stay updated on Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial

Sign up to get notified when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page’s footer version label was updated from one revision number to the next (v3.5.2 → v3.5.3), reflecting a site/display revision rather than any changes to the clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-24T06:43:38.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.5.2 replaces the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:52:26.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Added Rhabdomyosarcoma as a focus term and included Genetic and Rare Diseases Information Center as a Resources link. Updated page revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-19T06:23:48.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3. This appears to be a minor site maintenance update with no changes to study details or visible features.
    Difference
    0.1%
    Check dated 2026-03-12T02:32:12.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Revision updated to v3.4.2. The prior funding-status notice and revision v3.4.1 were removed.
    Difference
    0.4%
    Check dated 2026-02-11T11:25:42.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    A site-wide notice about government funding and NIH Clinical Center operating status has been added, with links to cc.nih.gov and opm.gov. A revision note updated the site version from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T07:54:31.000Z thumbnail image

Stay in the know with updates to Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.